Patent eliquis?

When does Pfizer's Patents for Eliquis expire?

Pfizer's anticoagulant medication Eliquis, marketed in combination with Bristol Myers Squibb (BMS), holds a strong patent portfolio that has shielded it from generic competition. However, a recent study at DrugPatentWatch.com revealed the patent's expiry timelines.

Why are companies not challenging Eliquis's patents yet?

Despite the potential for millions in savings, pharmaceutical companies have yet to challenge Pfizer and Bristol Myers Squibb's patents due to the complex and costly process. Patent litigation can take years, and manufacturers may not want to risk financial losses from an adverse ruling.

What is the current patent status of Eliquis?


A review of publicly available data shows that Pfizer and Bristol Myers Squibb's patents for Eliquis will begin to expire in 2027. However, multiple extensions have been granted due to ongoing clinical trials [1], which can further delay generic competition. Eliquis patents also hold Orange Book-listed exclusivity until 2037 [2][3].

Will biosimilars enter the market before patent expiry?

Due to the strict regulatory framework, biosimilar entry into the US market is possible. Biosimilar approval for Eliquis has not been granted yet, but the FDA has approved a few other biosimilars for different products [4].

What impact will patent expiry have?

The expiration of Eliquis's patents may lead to price competition from generic versions, benefiting patients with limited budgets. Additionally, it will provide an opportunity for companies to manufacture cheaper alternatives, thereby increasing access to essential treatments.

Who else is involved in this patent situation?

Companies such as Mylan and Sandoz are also involved in patent litigation for Eliquis, with ongoing cases filed before the federal courts [5]. However, the exact outcome remains uncertain.

Cited Sources:

[1] Eliquis.com - Clinical Trials

[2] FDA - Orange Book Listing

[3] drugpatentwatch.com

[4] FDA.gov - Biosimilars

[5] Court Records: Eliquis Litigation(Search for “Eliquis” cases).